Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”
Journal of Clinical Oncology | July 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1200/jco-26-01153
| PMID 42430671